# NMB

## Overview
The NMB gene encodes the neuromedin B (NMB) protein, a member of the bombesin-like peptide family, which is involved in various physiological processes, including chondrogenesis and nociceptive signaling. The NMB protein is characterized by a 76-amino acid precursor that undergoes post-translational modifications essential for its biological activity (Krane1988Molecular). It is predominantly expressed in the brain and gastrointestinal tract, with notable presence in the hypothalamus and pituitary gland (Krane1988Molecular). Functionally, NMB interacts with the neuromedin B receptor (NMBR), a G-protein-coupled receptor, to mediate signaling pathways that regulate intracellular calcium levels and influence pain and inflammation responses (Mishra2012A; Zhang2012Neuromedin). Clinically, dysregulation of NMB and its receptor has been associated with conditions such as Cushing's disease and certain cancers, highlighting its potential as a therapeutic target (Sekizaki2023Neuromedin).

## Structure
The neuromedin B (NMB) protein is encoded by the NMB gene and is part of the bombesin-like peptide family. The primary structure of NMB includes a 76-amino acid precursor, which features a hydrophobic signal sequence followed by the sequence of NMB-32 and a 17-amino acid carboxyl-terminal extension peptide (Krane1988Molecular). The NMB sequence forms the last 10 amino acids of NMB-32 and is flanked by monobasic and dibasic cleavage sites (Krane1988Molecular). 

The NMB protein undergoes post-translational modifications, including amidation, which is crucial for its biological activity (Krane1988Molecular). The protein is widely distributed in the brain and gastrointestinal tract, with high levels of expression in the hypothalamus, pituitary, olfactory bulb, spinal cord, and pineal gland (Krane1988Molecular). 

The NMB gene is located on the long arm of chromosome 15, and genomic DNA analysis suggests a single NMB gene in humans (Krane1988Molecular). Despite its structural similarities to other bombesin-like peptides, the specific secondary, tertiary, and quaternary structures of NMB have not been detailed in the available literature.

## Function
Neuromedin B (NMB) is a peptide that plays a significant role in the differentiation of mesenchymal stromal cells (MSCs) into chondrocytes, which are essential for cartilage formation. NMB is upregulated during the early stages of chondrogenesis and acts in an autocrine manner to regulate intracellular calcium levels, which are critical for successful chondrogenesis (Maumus2021Neuromedin). The binding of NMB to its receptors activates phospholipase C (PLC), leading to the production of inositol 1,4,5-triphosphate (IP3) and the release of calcium from the endoplasmic reticulum. This calcium influx is crucial for activating the calcineurin/NFAT signaling pathway, which in turn upregulates the chondrogenic transcription factor Sox9, promoting chondrocyte differentiation (Maumus2021Neuromedin).

NMB is also involved in nociceptive signaling within the nervous system, where it is expressed in peripheral sensory neurons. It plays a role in inducing hyperalgesia and neurogenic swelling at injury sites, indicating its involvement in pain and inflammation pathways (Mishra2012A). NMB's receptor, NMBR, is expressed in neurons in the spinal cord, suggesting a specific role in thermal nociception (Mishra2012A).

## Clinical Significance
Alterations in the expression of the Neuromedin B (NMB) gene and its receptor (NMBR) have been implicated in several clinical conditions. In the context of Cushing's disease, NMB and NMBR are expressed at higher levels in corticotroph adenomas compared to other types of pituitary adenomas. This overexpression is associated with excessive cortisol production, a hallmark of Cushing's disease. The use of NMBR antagonists, such as PD168368, has shown potential in reducing proopiomelanocortin (Pomc) mRNA/protein expression, ACTH secretion, and cell proliferation in corticotroph tumor cells, suggesting a therapeutic role for targeting NMBR in this condition (Sekizaki2023Neuromedin).

In cancer, alterations in NMB expression have been linked to tumor growth and progression. NMB's role in cell signaling pathways may influence tumor growth, as it is involved in various physiological processes that can affect cellular proliferation and energy homeostasis. Although specific mutations in the NMB gene itself are not detailed in the provided context, its altered expression and interaction with its receptor are significant in the pathophysiology of certain cancers (Sekizaki2023Neuromedin).

## Interactions
Neuromedin B (NMB) interacts with its receptor, the neuromedin B receptor (NMBR), which is a G-protein-coupled receptor. This interaction is crucial for various signaling pathways. In rat pancreatic membranes, NMB binds to a common phosphoinositide-coupled receptor shared with bombesin (BB) and neuromedin C (NMC), but it shows differential sensitivity to guanine nucleotides compared to BB. This suggests that NMB and BB, while binding to the same receptor, may couple to different G-proteins, leading to distinct physiological responses (Sekar1991Bombesin).

In myometrial primary cells in mice, NMB influences the activity of the Rela/p65 pathway, a component of the NF-kB transcription factor complex. NMB up-regulates the DNA binding activity of Rela/p65, which is essential for the regulation of IL6 expression. This interaction is mediated through the NMBR and is blocked by NMBR-specific siRNA, indicating a direct interaction between NMB and the Rela/p65 pathway (Zhang2012Neuromedin).

NMB also affects intracellular calcium levels in myometrial cells, a process that involves the NMBR and the Rela/p65 pathway. This regulation of calcium signaling suggests that NMB's interaction with its receptor and associated pathways is complex and involves multiple signaling mechanisms (Zhang2012Neuromedin).


## References


[1. (Krane1988Molecular) I M Krane, S L Naylor, D Helin-Davis, W W Chin, and E R Spindel. Molecular cloning of cdnas encoding the human bombesin-like peptide neuromedin b. chromosomal localization and comparison to cdnas encoding its amphibian homolog ranatensin. Journal of Biological Chemistry, 263(26):13317–13323, September 1988. URL: http://dx.doi.org/10.1016/s0021-9258(18)37707-x, doi:10.1016/s0021-9258(18)37707-x. This article has 69 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)37707-x)

[2. (Sekizaki2023Neuromedin) Tomonori Sekizaki, Hiraku Kameda, Akinobu Nakamura, Saki Kuwabara, Hiroshi Nomoto, Kyu Yong Cho, Yukitomo Ishi, Hiroaki Motegi, Hideaki Miyoshi, and Tatsuya Atsumi. Neuromedin b receptor as a potential therapeutic target for corticotroph adenomas. Pituitary, 26(5):597–610, August 2023. URL: http://dx.doi.org/10.1007/s11102-023-01350-3, doi:10.1007/s11102-023-01350-3. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11102-023-01350-3)

[3. (Zhang2012Neuromedin) Wei-She Zhang, Kui-Lin Fei, Mei-Ting Wu, Xin-Hua Wu, and Qing-Hua Liang. Neuromedin b and its receptor influence the activity of myometrial primary cells in vitro through regulation of il6 expression via the rela/p65 pathway in mice1. Biology of Reproduction, May 2012. URL: http://dx.doi.org/10.1095/biolreprod.111.095984, doi:10.1095/biolreprod.111.095984. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1095/biolreprod.111.095984)

[4. (Maumus2021Neuromedin) Marie Maumus, Guillaume Fonteneau, Maxime Ruiz, Said Assou, Hassan Boukhaddaoui, Philippe Pastoureau, Frédéric De Ceuninck, Christian Jorgensen, and Danièle Noel. Neuromedin b promotes chondrocyte differentiation of mesenchymal stromal cells via calcineurin and calcium signaling. Cell &amp; Bioscience, October 2021. URL: http://dx.doi.org/10.1186/s13578-021-00695-1, doi:10.1186/s13578-021-00695-1. This article has 6 citations.](https://doi.org/10.1186/s13578-021-00695-1)

[5. (Sekar1991Bombesin) M C Sekar, N Uemura, D H Coy, B I Hirschowitz, and K E J Dickinson. Bombesin, neuromedin b and neuromedin c interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. Biochemical Journal, 280(1):163–169, November 1991. URL: http://dx.doi.org/10.1042/bj2800163, doi:10.1042/bj2800163. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj2800163)

[6. (Mishra2012A) S. K. Mishra, S. Holzman, and M. A. Hoon. A nociceptive signaling role for neuromedin b. Journal of Neuroscience, 32(25):8686–8695, June 2012. URL: http://dx.doi.org/10.1523/JNEUROSCI.1533-12.2012, doi:10.1523/jneurosci.1533-12.2012. This article has 62 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1523/JNEUROSCI.1533-12.2012)